Apex Healthcare Berhad (KLSE:AHEALTH)
2.610
0.00 (0.00%)
Inactive · Last trade price on Jan 12, 2026
Apex Healthcare Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,886 | 1,779 | 1,789 | 1,681 | 1,281 | 1,682 | |
Market Cap Growth | 4.73% | -0.55% | 6.40% | 31.22% | -23.83% | 59.11% |
Enterprise Value | - | 1,627 | 1,420 | 1,545 | 1,130 | 1,548 |
Last Close Price | - | 2.38 | 2.19 | 2.01 | 1.48 | 1.91 |
Price Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
PE Ratio | - | 23.24 | 4.49 | 16.65 | 21.56 | 30.02 |
Forward PE | - | 18.27 | 18.68 | 20.09 | 20.71 | 27.70 |
PS Ratio | - | 1.85 | 1.91 | 1.92 | 1.66 | 2.41 |
PB Ratio | - | 2.25 | 1.95 | 3.01 | 2.53 | 3.59 |
P/TBV Ratio | - | 2.27 | 1.95 | 3.02 | 2.54 | 3.61 |
P/FCF Ratio | - | 43.35 | 45.56 | 40.26 | 25.19 | 24.14 |
P/OCF Ratio | - | 25.78 | 27.44 | 23.33 | 20.72 | 19.67 |
PEG Ratio | - | 0.87 | 0.81 | 1.29 | 4.14 | 4.70 |
EV Ratios
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
EV/Sales Ratio | - | 1.69 | 1.52 | 1.76 | 1.47 | 2.22 |
EV/EBITDA Ratio | - | 13.22 | 14.87 | 15.00 | 13.98 | 20.67 |
EV/EBIT Ratio | - | 15.63 | 18.02 | 17.61 | 17.20 | 25.93 |
EV/FCF Ratio | - | 39.65 | 36.16 | 37.00 | 22.21 | 22.22 |
Financial Efficiency
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.06 | 0.07 | 0.01 | 0.03 | 0.04 | 0.06 |
Debt / EBITDA Ratio | 0.41 | 0.45 | 0.11 | 0.15 | 0.26 | 0.37 |
Debt / FCF Ratio | 0.42 | 1.39 | 0.27 | 0.38 | 0.42 | 0.40 |
Asset Turnover | 0.96 | 0.90 | 1.00 | 1.23 | 1.19 | 1.16 |
Inventory Turnover | 5.52 | 5.68 | 6.07 | 6.61 | 6.51 | 6.17 |
Quick Ratio | 2.54 | 2.49 | 3.03 | 2.07 | 2.33 | 2.16 |
Current Ratio | 3.35 | 3.32 | 3.70 | 2.72 | 2.97 | 2.82 |
Return on Equity (ROE) | 8.30% | 8.96% | 53.90% | 18.96% | 12.19% | 12.54% |
Return on Assets (ROA) | 6.14% | 6.11% | 5.27% | 7.69% | 6.31% | 6.19% |
Return on Invested Capital (ROIC) | 11.41% | 13.45% | 15.75% | 20.19% | 15.88% | 14.58% |
Return on Capital Employed (ROCE) | 11.90% | 12.30% | 8.50% | 15.30% | 12.40% | 12.40% |
Yields
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Earnings Yield | - | 4.30% | 22.25% | 6.01% | 4.64% | 3.33% |
FCF Yield | - | 2.31% | 2.20% | 2.48% | 3.97% | 4.14% |
Dividend Yield | 3.45% | 3.79% | 2.29% | 2.15% | 2.48% | 1.57% |
Payout Ratio | 99.07% | 79.95% | 8.72% | 28.36% | 42.45% | 31.30% |
Buyback Yield / Dilution | -0.07% | -0.09% | -0.16% | -0.33% | 0.14% | -0.34% |
Total Shareholder Return | 3.38% | 3.69% | 2.13% | 1.83% | 2.63% | 1.23% |